-
Rob Verkerk PhD on TNT Mind Medicine show
15 February 2023
ANH founder, Rob Verkerk PhD, got up extra early to join Charles Kovess on the Mind Medicine show on TNT Radio recently
-
ANH News Beat (week 11/2023)
16 March 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
ANH News Beat (week 7/2023)
15 February 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
News Alerts: Week 12, 2020
19 March 2020
Lyn Thyer released!; Telemedicine & coronavirus; ICNIRP declares 5G safe; Food packaging chemicals harmful to health; Gluten damages brain health; And finally…;
-
Weekly news update (week 17, 2021)
28 April 2021
Truth Over Fear Summit; Scientists call for covid restrictions end; Vaccine adverse reactions; Covid vaccines & pregnancy; German judge intimidated; New GMO film released; London Freedom March; Mask wearing unsafe; Nutritional therapy improves health & wellbeing; Danish dietary guidelines
-
Is the semi-natural sweetener erythritol as bad as aspartame?
16 March 2023
ANH-USA's medical director, Ron Hoffman MD, examines a new study suggesting low-carb sweetener erythritol increases heart attack risk - all is not as the headlines profess!
News / Food4Health Campaign / Health / Food / Campaigns
-
Pathfinder Members' Briefing and Q&A - March 2023
23 March 2023
Zoom recording of our Pathfinder members' briefing and Q&A for March 2023
-
Pathfinder Members' Briefing and Q&A - March 2023
23 March 2023
Zoom recording of our Pathfinder members' briefing and Q&A for March 2023
-
News Alerts: Week 52, 2020
23 December 2020
High blood sugar levels & covid-19; Genetic engineering health risks; Junk food harms teen sleep; An avocado a day keeps your gut microbes happy; BAME community & vitamin D deficiency; Ayurveda & covid-19
-
Regulatory limbo: the case of NAC
13 April 2023
The more effective a natural product, the greater the risk if it sits in an uncertain, regulatory ‘no man’s land’